WCM
EW icon

Wedge Capital Management’s Edwards Lifesciences EW Stock Holding History

Wedge Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-42,000
Closed -$997K – 593
2015
Q2 		$997K Buy
42,000
+7,950
+23% +$179K 0.01% 326
2015
Q1 		$808K Buy
34,050
+600
+2% +$13.5K 0.01% 351
2014
Q4 		$710K Sell
33,450
-12,900
-28% -$259K 0.01% 381
2014
Q3 		$789K Buy
+46,350
New +$732K 0.01% 364

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Wedge Capital Management's EW Position: Q3 2015 in Review

Wedge Capital Management sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 42,000 shares — an estimated $997K sold.

Wedge Capital Management first reported a position in EW in Q3 2014 and held it in 4 quarters. The position peaked at $997K in Q2 2015. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

  • Wedge Capital Management reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
  • Wedge Capital Management sold 42,000 Edwards Lifesciences shares in Q3 2015, an estimated $997K.
  • Wedge Capital Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 4 quarters.
  • Wedge Capital Management's Edwards Lifesciences position peaked at $997K in Q2 2015.
  • 569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Wedge Capital Management's 13F filing for Q3 2015, filed 9 Nov 2015.